SecBot SecBot
SECBOTREPLAY Home › Report › LFCR

LFCR · Lifecore Biomedical announced a manufacturing services agreement with a…

Lifecore Biomedical, Inc. · PRESS-RELEASE filed Jun 2, 2026 at 07:05 ET

At the news

NEUTRALIMPACT 4/10

PRESS-RELEASE filed Jun 2, 2026 at 07:05 ET

Lifecore Biomedical announced a manufacturing services agreement with a leading ophthalmic disease management provider for process development and tech transfer of a next-generation reformulation from vials to pre-filled syringes. This is the sixth late-stage pipeline addition in seven months, but no financial terms or revenue commitments were disclosed.

  • Agreement covers process development and technical transfer services for an injectable ophthalmic product.
  • Program involves transitioning a commercially approved product from vials to pre-filled syringes.
  • This is the sixth late-stage pipeline addition in seven months.
  • No financial terms, deal value, or revenue guidance were disclosed.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access